Three-peat For Deceuninck – Quick-step With Another Stage Win At Midpoint Of The 2019 Amgen Tour Of California
May 15, 2019
Leader Board Holds after Perilous Ride into Morro Bay. Tomorrow Marks Longest Stage for the 7-day Race with 136 Miles from Pismo Beach to Ventura
MORRO BAY, Calif. (May 15, 2019) – The Amgen Tour of California Stage 4 presented by Lexus ended with the expected sprinter shootout – UAE Emirates’ Jasper Philipsen (BEL) launched the final attack to the finish line, trailed by BORA-hansgrohe’s three-time World Champion Peter Sagan (SVK). With just meters to go, Deceuninck – Quick-Step’s Fabio Jakobsen (NED) rocketed past both to claim the team’s third stage in three days. Cofidis, Solutions Credits Nacer Bouhanni (FRA) followed the trio across the line in fourth place.
Sagan, who won the 2017 Morro Bay stage on this same finish route, took third place today and moves into the green jersey, which he has worn regularly during his years at this race.
Meanwhile, the peloton encountered the unexpected. When race leader Tejay van Garderen (Tacoma, Wash.) came off his bike and suffered a mechanical issue with about 5 miles left to ride, EF Education First Pro Cycling teammate Lachlan Morton (AUS) offered up his bike and the team worked to pace their leader back up to the main group. A crash at the back of the peloton that affected multiple GC riders neutralized the time gap that resulted, with the leader board ending up unchanged after today’s stage.
A rain-dotted ride from WeatherTech Raceway Laguna Seca to Morro Bay featured the iconic coastal views of Central California’s Highway 1, which has reopened after a massive effort by Caltrans to repair damage from a 2017 landslide.
The breakaway that held for most of the 133.3-mile stage included two current National Champions – Hagens Berman Axeon’s Jonny Brown (Knoxville, Tenn.) and Israel Cycling Academy’s Roy Goldstein (ISR) – as well as Brown’s teammate Ian Garrison (Decatur, Georgia), Team Novo Nordisk’s Joonas Henttala (FIN), and USA Cycling National Team’s Michael Hernandez (Claremont, Fla.).
Hernandez was the last to be caught with just over 5 miles to go and earned the Breakaway from Cancer® Most Courageous Rider Jersey. USA Cycling National Team will have two riders in jerseys tomorrow with teammate and reigning U.S. U23 National Champion Alex Hoehn (Lenexa, Kansas) retaining the polka dot jersey.
The peloton of 19 teams (132 riders) representing 33 countries includes three World Champions, Olympians, Tour de France stage winners and six current National Road Race Champions from around the world. Throughout the week, cyclists will contest 773 miles of California’s most scenic highways, mountain roads and coastlines, visiting 13 cities throughout the state for stage starts and finishes, concluding in Pasadena on May 18.
Tomorrow’s Stage 5 presented by Lexus from Pismo Beach to Ventura is the longest road day of the week at 136.4 miles.
Also tomorrow, the Amgen Tour of California Women's Race empowered with SRAM UCI WorldTour race kicks off in Ventura, showcasing the world’s best women cyclists. It will run concurrently for the final three days of the men’s event, May 16-18.
Amgen Tour of California fans can connect with the race through all of their favorite social media platforms and use #AmgenTOC to join the conversation.
Amgen, title sponsor of the Amgen Tour of California for the 14th consecutive year, is a biotechnology company in the race to dramatically improve patients’ lives and the company leverages its sponsorship to raise awareness and connect with patients through its Breakaway initiatives.
On May 1, Amgen launched the Breakaway Challenge, a national social fitness movement to motivate individuals to take action in their health and to support the fight against heart disease and cancer. Amgen’s Breakaway Challenge joins together Breakaway from Cancer® and Breakaway from Heart Disease™ and urges participants to turn their walking, running or cycling miles into support for eight nonprofit advocacy organizations that are dedicated to cancer and heart disease research.
Amgen has teamed up with Strava, a social fitness app that tracks cycling and running activities, to create the Breakaway Challenge. Strava will aggregate the total miles contributed to the Breakaway Challenge with the goal to collectively reach as many miles as possible with Amgen matching the first 400,000 miles with a $400,000 donation evenly distributed to the independent, nonprofit partners. Today, 12,674,241 miles toward the Breakaway Challenge have been logged. Join Amgen and make this the biggest Challenge ever. Learn more at www.AmgenBreakawayChallenge.com.
“Building and connecting with communities is at the core of Amgen’s Breakaway initiatives and we are incredibly pleased with the community forming as part of the Breakaway Challenge,” said Corrine Le Goff, Senior Vice President, General Manager, General Medicine, Amgen. “Amgen is more committed than ever to scientific innovation and to building a community of support for patients. It takes a team to win the Amgen Tour of California, it takes a team to make great strides in scientific innovation and it takes a community to educate, support and empower patients. Join our Breakaway Challenge community today.”
Created by Amgen in 2005, Breakaway from Cancer® is a national initiative to raise awareness of the important resources available to people impacted by cancer – from prevention to survivorship. And, the Breakaway from Heart Disease™ initiative encourages Americans to take charge of their risk of heart disease through diagnostic screenings as well as information and tools related to physical activity and healthy eating. Learn more at www.breakawayfromcancer.com and www.breakawayfromheartdisease.com.
Throughout the race, Amgen will honor and celebrate patients. Each day the race will be started by a cancer or heart disease survivor, and the Most Courageous jersey will be awarded by a survivor as well. Cyclists will also wear Breakaway “I Ride For” bibs recognizing someone in their life impacted by cancer or heart disease.
“Creating powerful connections in the communities is part of our mission to develop vital medicines and serve more patients who suffer from serious diseases. This is how we make a difference in the world; every patient, every time,” continued Le Goff. “Today’s healthcare options for treating serious illness are more promising than at any other time in our history. Now more than ever, patients living with serious diseases such as cancer and cardiovascular disease can look to the future with greater hope. Our sponsorship of the Amgen Tour of California gives us a platform to discuss, educate and empower patients to have hope and believe in innovation to live a longer, healthier life.”
For more information, visit www.amgen.com.
About the Amgen Tour of California
The Amgen Tour of California and the Amgen Tour of California Women's Race empowered with SRAM are Tour de France-style cycling road races created and presented by AEG. Running concurrently, the races challenge the world's top professional cycling teams to compete along demanding courses that traverse hundreds of miles of California's iconic highways, byways and coastlines each spring. The teams chosen to participate have included Olympic medalists, Tour de France contenders and World Champions, and award important, world-ranking points to the top finishers. For more information visit the Amgen Tour of California on Instagram, Facebook, Twitter, YouTube or www.amgentourofcalifornia.com.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be the world's largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Headquartered in Los Angeles, California, AEG is the world’s leading sports and live entertainment company. With offices on five continents, AEG operates in the following business segments: AEG Facilities, which is affiliated with or owns, manages or consults with more than 150 preeminent arenas, stadiums, theaters, clubs and convention centers around the world including STAPLES Center, The O2 Arena, the Sprint Center and the Mercedes-Benz Arenas; AEG Presents, which is dedicated to all aspects of live contemporary music performances, including producing and promoting global and regional concert tours, music and special events and world-renowned festivals; AEG Real Estate, which develops world-class venues, as well as major sports and entertainment districts like STAPLES Center and L.A. LIVE; AEG Sports, which is the world’s largest operator of sports franchises and high-profile sporting events; and AEG Global Partnerships, which oversees worldwide sales and servicing of sponsorships including naming rights, premium seating and other strategic partnerships. Through its worldwide network of venues, portfolio of powerful sports and music brands, AXS.com ticketing platform, AXS cable television channel and its integrated entertainment districts, AEG entertains more than 100 million guests annually. More information about AEG can be found at www.aegworldwide.com.
# # #
Michael Roth, AEG
Josh Levitt, Canvas Blue